Iqvia

Iqvia

https://www.iqvia.com/
https://www.linkedin.com/company/iqvia/

Iqvia, also known as IQVIA Holdings, is a Publicly Owned company headquartered in the United States. Founded in 1982, the company employs approximately 72,660 individuals and reported $16.3B in revenue as of 2025. Functioning primarily in the Hospitals and Health Care sector, it specializes in providing advanced analytics, technology solutions, and clinical research services to the life sciences industry.

2025 Revenue

Founded

1982

Headcount

93,000

Headquarters

United States

Primary Segment

Hospitals and Health Care

Ownership

Publicly Owned

News Summary:

On October 2, 2026, Italy's data protection authority, Garante per la protezione dei dati personali, ordered IQVIA Solutions Italy S.r.l. to pay 7 million euros. This fine, stemming from Decision No. 710 adopted on September 23, addressed the company's handling of health records for approximately one million patients, which it gathered from about 800 general practitioners. The authority determined that a hash preserving uniqueness in the data did not constitute anonymity, contrary to the company's assertion.

Similar Companies

Subscribe for full access to Iqvia's profile

Subscribe for full access to Iqvia's products in full detail

Subscribe for full access to Iqvia's revenue in full detail

Oct

6th

2026

06:35

Partnerships and Alliances, Artificial Intelligence, B2B Tag, Partnerships, Product Updates

Clinical Trial Management System Market Gains Momentum as More Than 200 Companies Adopt Veeva CTMS

The Clinical Trial Management System (CTMS) market is gaining traction as digital platforms become central to increasingly complex clinical research operations. In January 2025, Veeva Systems announced that more than 200 companies, including 17 of the top 20 biopharmaceutical companies, were using Veeva CTMS to improve trial efficiency and collaboration.

Oct

3rd

2026

23:33

Emerging Tech, Legal Issues and Lawsuits, Data Breach, Regulatory Compliance

Italy fines IQVIA 7m euros over patient records it called anonymous

A hash that preserves uniqueness is not anonymity The Italian data protection authority has put a price on a claim that large parts of the advertising industry make every day. In Decision No. 710, adopted on September 23, 2026 and published on October 2, the Garante per la protezione dei dati personali ordered IQVIA Solutions Italy S.r.l. to pay 7 million euros over the handling of health records belonging to roughly one million patients, gathered from about 800 general practitioners.

Oct

1st

2026

04:06

B2B Tag, M&A Activities, Funding

Primary Care Clinical Pharmacy M&A in 2026

Managed clinical pharmacy providers have established an important position within primary care, predominantly through services funded by the Additional Roles Reimbursement Scheme (ARRS) and delivered to Primary Care Networks (PCNs) and GP practices. Alongside the deployment of clinical pharmacists and pharmacy technicians, they organise recruitment, training, clinical supervision and continuity of service.

Sep

22nd

2026

06:30

Management Changes, M&A Activities, M&A Activities, Management Changes

How To Choose A Contract Sales Organization For A 2027 Launch

By Hoyt Gong A company launching a drug in the United States in 2027 will hire its contract sales organization (CSO) from a market that has changed since its executives last bought from it. Five of the best-known providers have new owners, new chief executives, or a new reporting structure.

Life Science Leader

Sep

22nd

2026

06:30

Why Does Published Payer Coverage Differ From Actual Patient Access?

Published payer coverage can differ from actual patient access because coverage is only one part of the patient journey. Prior authorization, claim rejection, specialty pharmacy routing, patient cost, plan mapping, timing, and incomplete downstream data can prevent or obscure a patient start.

Sep

22nd

2026

06:30

8 Top Full-Service CRO Companies Supporting Global Drug Development

Global drug development requires coordinated execution across scientific strategy, clinical sites, data management, patient safety, regulatory requirements, and project delivery. A full-service contract research organization (CRO) can bring these functions together within a coordinated operating model, while drawing on specialist support where appropriate.

Sep

9th

2026

18:30

Emerging Tech, Artificial Intelligence, B2B Tag, Target Customer Expansion

AI-Based Clinical Trials Solution Provider Market Global & Geographic Analysis with Growth Forecast to 2034

What is the AI-Based Clinical Trials Solution Provider Market? The AI-based clinical trials solution provider market comprises companies that develop and deliver artificial intelligence-enabled software, platforms, analytics, and technology-supported services designed to improve the planning, execution, monitoring, analysis, and management of clinical trials.

Htfmarketintelligence

Sep

9th

2026

00:00

GENFIT Highlights Long-Term Commercial Opportunity for its MASH Diagnostics Technology

Simple, reliable and scalable blood-based testing could identify patients with at-risk MASH among nearly 90 million U.S. individuals receiving medical attention due to MASLD-related risk factors IQVIA estimates U.S peak sales of products based on

Aug

31st

2026

15:22

Financial Results, Financial Performance

Q2 Earnings Roundup: IQVIA (NYSE:IQV) And The Rest Of The Drug Development Inputs & Services Segment

As the Q2 earnings season comes to a close, it's time to take stock of this quarter's best and worst performers in the drug development inputs & services industry, including IQVIA (NYSE:IQV) and its peers. Companies specializing in drug development inputs and services play a crucial role in the pharmaceutical and biotechnology value chain.

Aug

21st

2026

06:58

Management Changes, Artificial Intelligence, Management Changes, Regulatory Compliance

Mike King, Senior Director, Product & Strategy, IQVIA- Interview Series

Mike King, Senior Director, Product & Strategy, IQVIA, is an experienced healthcare and life sciences executive with more than two decades of experience spanning product strategy, regulatory affairs, quality assurance, operations, and business transformation. Before joining IQVIA in 2022, King held senior leadership positions at Dentsply Sirona and GE Healthcare, where he oversaw regulatory affairs across complex international markets, including Europe, Russia, the Commonwealth of Independent States (CIS), Israel, the Middle East, Africa, and Asia.

Aug

19th

2026

01:56

Devices are Getting Smarter, Making Materiovigilance Evolve Faster

Insights shared by industry relative to healthcare and the advancement of medical technology. Dr. Padmalakshmi Jnaneshwar is Director, Safety Operations, in Lifecycle Safety at IQVIA where she leads ssafety operations, regulatory reporting and project management teams supporting medical device pharmacovigilance, drug safety for clinical trials and post-marketing products, Materiovigilance is the process of monitoring, evaluating and reporting on safety issues related to medical devices available to the market.

MedTech Intelligence

Aug

18th

2026

02:02

Advanced Manufacturing, Artificial Intelligence, B2B Tag

Clinical Trial Patient Recruitment Services Market Outlook Signals Expansion To $4.98 Billion Through 2030

The clinical trial patient recruitment services sector is poised for significant expansion as the pharmaceutical and biotechnology industries increasingly seek efficient ways to enroll participants. With technological advancements and evolving trial methodologies, this market is set to play a crucial role in accelerating clinical research timelines and improving patient engagement.

Iqvia has suppliers like Spectra Logic.

Example Suppliers

Subscribe for full access to Iqvia's profile

Analyst insight reports

Beyond video: the opportunity for digital lifestyle services

Sustainability in media technology: Understanding the state of sustainability practices

Trendspotting: sports content in 2025 and beyond

Charting the rise of short-form sports content

Subscribe to access all analyst insight reports